Source:http://linkedlifedata.com/resource/pubmed/id/16639099
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
2006-4-26
|
| pubmed:abstractText |
Results from clinical trials do not necessarily provide information for decisions in clinical practice. This review aims to present strengths and limitations of different methodological types of clinical trials and to offer an overview of how knowledge from clinical trails can be distilled for clinical practice. Selected key questions in the treatment of schizophrenia are presented, with a focus on the possibilities and restrictions of translating trial results into real-world practice.
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:status |
PubMed-not-MEDLINE
|
| pubmed:month |
Nov
|
| pubmed:issn |
0951-7367
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
18
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
692-9
|
| pubmed:dateRevised |
2007-3-20
|
| pubmed:year |
2005
|
| pubmed:articleTitle |
Clinical trial design in schizophrenia: implications for clinical decisions.
|
| pubmed:affiliation |
Department of Psychiatry and Psychotherapy, The Saarland University Hospitals, Homburg, Germany. frank.pajonk@uniklinik-saarland.de
|
| pubmed:publicationType |
Journal Article
|